Elsevier

Brain Research

Volume 1647, 15 September 2016, Pages 19-29
Brain Research

Review
There has been an awakening: Emerging mechanisms of C9orf72 mutations in FTD/ALS

https://doi.org/10.1016/j.brainres.2016.04.004Get rights and content
Under a Creative Commons license
open access

Highlights

  • Three C9orf72 disease mechanisms are reviewed.

  • Evidence in favor of each mechanism presented.

  • Evidence against each mechanism presented.

  • Suggestions for experiments to test each mechanism further presented.

Abstract

The discovery of C9orf72 mutations as the most common genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) has awakened a surge of interest in deciphering how mutations in this mysterious gene cause disease and what can be done to stop it. C9orf72 harbors a hexanucleotide repeat, GGGGCC, in a non-coding region of the gene and a massive expansion of this repeat causes ALS, FTD, or both (FTD/ALS). Many questions lie ahead. What does this gene normally do? What is the consequence of an enormous GGGGCC repeat expansion on that gene's function? Could that hexanucleotide repeat expansion have additional pathological actions unrelated to C9orf72 function? There has been tremendous progress on all fronts in the quest to define how C9orf72 mutations cause disease. Many new experimental models have been constructed and unleashed in powerful genetic screens. Studies in mouse and human patient samples, including iPS-derived neurons, have provided unprecedented insights into pathogenic mechanisms. Three major hypotheses have emerged and are still being hotly debated in the field. These include (1) loss of function owing to decrease in the abundance of C9orf72 protein and its ability to carryout its still unknown cellular role; (2) RNA toxicity from bidirectionally transcribed sense (GGGGCC) and antisense (GGCCCC) transcripts that accumulate in RNA foci and might sequester critical RNA-binding proteins; (3) proteotoxicity from dipeptide repeat proteins produced by an unconventional form of translation from the expanded nucleotide repeats. Here we review the evidence in favor and against each of these three hypotheses. We also suggest additional experiments and considerations that we propose will help clarify which mechanism(s) are most important for driving disease and therefore most critical for considering during the development of therapeutic interventions.

This article is part of a Special Issue entitled SI:RNA Metabolism in Disease.

Keywords

ALS, FTD
C9orf72
RNA
Dipeptide repeat protein

Cited by (0)